Zobrazeno 1 - 7
of 7
pro vyhledávání: '"W. J. Heinz"'
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 139:1216-1219
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fda3f9177815e17f36d9888aaf23d4c5
https://doi.org/10.1055/s-0034-1370033
https://doi.org/10.1055/s-0034-1370033
Autor:
F. Weissinger, W. J. Heinz
Publikováno v:
memo - Magazine of European Medical Oncology. 5:30-34
Febrile Neutropenia is a relevant factor for mortality after chemotherapy. Dependent upon factors like duration of neutropenia (≥7 d means high-risk situation), patient- and disease specific criteria e.g. defined in the MASCC score (Multinational A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1349e54cddb5ccabcb3a8d7c82108802
https://doi.org/10.1007/s12254-012-0335-2
https://doi.org/10.1007/s12254-012-0335-2
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 139(23)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::574b7fbea88f5bd14c708cff4bb6921d
https://pubmed.ncbi.nlm.nih.gov/24866953
https://pubmed.ncbi.nlm.nih.gov/24866953
Autor:
G, Maschmeyer, W J, Heinz, B, Hertenstein, H-A, Horst, C, Requadt, T, Wagner, O A, Cornely, J, Löffler, M, Ruhnke, Axel, Zander
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 32(5)
Empirical antifungal therapy is widely used in high-risk neutropenic hematology patients with fever persisting for more than 4 days. This clinical trial assessed whether immediate empirical therapy with voriconazole could lower the rates of invasive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936c189b4fcdd7b74b5d06267af5e54f
https://pubmed.ncbi.nlm.nih.gov/23271674
https://pubmed.ncbi.nlm.nih.gov/23271674
Publikováno v:
Zeitschrift fur Gastroenterologie. 50(3)
Here we present 3 patients with abdominal pain, weight loss and fever in combination with abdominal tumours which were all attributable to an ongoing mycobacterial infection. Worldwide, but especially in developing countries, tuberculosis is still an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a77bdbc94c6e4cf7f350049b2c3ab876
https://pubmed.ncbi.nlm.nih.gov/22383285
https://pubmed.ncbi.nlm.nih.gov/22383285
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 12(3)
Antifungal prophylaxis with posaconazole (POS) has been shown to decrease the mortality associated with invasive fungal infections in high-risk patients. We report on a patient, with severe graft-versus-host disease after allogeneic stem cell transpl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a32ff539b7d95aaa9ed5504a109db2c
https://pubmed.ncbi.nlm.nih.gov/19954497
https://pubmed.ncbi.nlm.nih.gov/19954497
Autor:
János Sinkó, Roger J. M. Brüggemann, Catherine Beigelman-Aubry, Jesús Fortún, Olivier Lortholary, Livio Pagano, Donald C. Sheppard, J Maertens, Murat Akova, Werner J. Heinz, Claudio Viscoli, Florence Ader, O. Marchetti, Katrien Lagrou, Bart Jan Kullberg, Paul E. Verweij, Oliver A. Cornely, Christoph Lange, Russell E. Lewis, Maria J G T Vehreschild, Patricia Muñoz, Manuel Cuenca-Estrella, Emilio Bouza, Thomas Lehrnbecher, Stijn Blot, José María Aguado, Elio Castagnola, Claus Peter Heussel, Jacques Cadranel, Malcolm Richardson, Christopher C. Kibbler, Jean-Pierre Gangneux, S. Arikan-Akdagli, George Dimopoulos, Raoul Herbrecht, Cornelia Lass-Flörl, Maurizio Sanguinetti, Rosemary Ann Barnes, Jürgen Löffler, David W. Denning, Anna Skiada, Jorge Garbino, Jacques F. Meis, Maiken Cavling Arendrup, Andrew J. Ullmann, Andreas H. Groll, Patricia Ribaud, Adilia Warris, Nikolay Klimko, Arunaloke Chakrabarti, Dieter Buchheidt, Emmanuel Roilides, Markus Ruhnke
Publikováno v:
ESCMID-ECMM-ERS 2018, ' Diagnosis and Management of Aspergillus Diseases: Executive Summary of the 2017 ESCMID-ECMM-ERS Guideline ', Clinical Microbiology and Infection . https://doi.org/10.1016/j.cmi.2018.01.002
Clinical Microbiology and Infection
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2018, 24 Suppl 1, pp.e1-e38. ⟨10.1016/j.cmi.2018.01.002⟩
Clinical Microbiology and Infection, 2018, 24 Suppl 1, pp.e1-e38. ⟨10.1016/j.cmi.2018.01.002⟩
Clinical Microbiology and Infection, 24 Suppl 1, e1-e38
Clinical Microbiology and Infection, 24 Suppl 1, pp. e1-e38
Clinical Microbiology and Infection
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2018, 24 Suppl 1, pp.e1-e38. ⟨10.1016/j.cmi.2018.01.002⟩
Clinical Microbiology and Infection, 2018, 24 Suppl 1, pp.e1-e38. ⟨10.1016/j.cmi.2018.01.002⟩
Clinical Microbiology and Infection, 24 Suppl 1, e1-e38
Clinical Microbiology and Infection, 24 Suppl 1, pp. e1-e38
Contains fulltext : 193204.pdf (Publisher’s version ) (Closed access) The European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory Society Joint Clinical Guideli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::510aa6dad1509646765db21a07cc0c5a
http://hdl.handle.net/10807/116936
http://hdl.handle.net/10807/116936
